Xeljanz 5 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DB25FJH53
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,529
Award facts
- Contract value 100% obligated
- $19,528.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,528.99 to AmerisourceBergen Drug Corp for 60 tablets of Xeljanz 5 mg on August 8, 2025, with completion expected by August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xeljanz is a prescription medication used primarily for rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical products that the Defense Logistics Agency procures to support military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and holds extensive contract relationships with the Defense Logistics Agency for delivering brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJH53?
SPE2DB25FJH53 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FJH53 worth?
The government has obligated $19,529 on SPE2DB25FJH53.
Is contract SPE2DB25FJH53 an order under another contract?
Yes. SPE2DB25FJH53 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJH53 competed?
The extent of competition for SPE2DB25FJH53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award